This site might not work as expected.
You're using an old browser that isn't supported by this site. Please upgrade or download one of these free and excellent browsers:

Wolters Kluwer Completes Acquire ProVation Medical, Inc.

​Shareholder of ProVation Medical, Inc. approve acquisition

Wolters Kluwer, a leading multinational publisher and information services company, today announced the completion of the acquisition of ProVation Medical, Inc. ProVation Medical provides medical documentation, coding and workflow solutions to hospitals and ambulatory surgery centers in the United States.  

Wolters Kluwer announced the acquisition of ProVation Medical, Inc. on January 4, 2006, which was completed after approval by the shareholders of privately-held Provation Medical, Inc. Financial details on the terms of the agreement were not disclosed. 

ProVation Medical, Inc. provides solutions that significantly enhance revenue and decrease costs per medical procedure. The ProVation platform will enable Wolters Kluwer Health to further pursue its strategy of providing the healthcare market with embedded medical content and workflow solutions at the point of care. 

ProVation Medical will become part of Wolters Kluwer Health’s Clinical Tools unit, which provides embedded content tools to pharmacies, hospitals, insurers and healthcare vendors. Under the brand names of Medi-Span, Facts & Comparisons, and Clin-eguide, these tools provide information on drug interactions and dosing, formulary guidelines, and evidence-based treatment plan options at the point of care. ProVation Medical’s 101 employees, including 10 physicians, and is based in Minneapolis.  

Jeff McCaulley, CEO of Wolters Kluwer Health, commented, “Integration of ProVation’s offerings with our current clinical information tools will greatly strengthen our offerings to the hospital and ambulatory surgery center markets. Our combined capabilities will create one of the most comprehensive portfolios of medical content across the many points of care at a time when organizations are looking to realize the full potential of their investments in electronic medical records.”

About Wolters Kluwer Health
Wolters Kluwer Health (Conshohocken, Pa.) is a leading provider of information for professionals and students in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Major brands include Lippincott Williams & Wilkins and Facts & Comparisons for medical and drug reference tools and textbooks; Ovid Technologies, Medi-Span and SKOLAR for electronic information; and Adis International and Source for pharmaceutical information. 

Wolters Kluwer is a leading multinational publisher and information services company. The Company's core markets are spread across the health, corporate services, financial services, tax, accounting, law, regulation, and education sectors. Wolters Kluwer has annual revenues (2004) of €3.3 billion, employs approximately 18,400 people worldwide and maintains operations across Europe, North America and Asia Pacific. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its depositary receipts of shares are quoted on the Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. For more information, see

This press release contains forward-looking statements. 
These statements may be identified by words such as "expect", "should", "could", "shall", and similar expressions. These statements are subject to risks and uncertainties, and actual results and events could differ materially from what is contemplated by the forward-looking statements. 
Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions, conditions in the markets in which Wolters Kluwer is engaged, behavior of customers, suppliers and competitors, technological developments, legal and regulatory rules affecting Wolters Kluwer's businesses and other risks and uncertainties regarding the timing and closing of the transactions described above, including the risk that the acquisition fails to close. In addition, financial risks, such as currency movements, interest rate fluctuations, liquidity and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. 
Wolters Kluwer disclaims any intention or obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.